Changeflow GovPing Pharma & Drug Safety EP4426712A1 - Processable Compositions Patent
Routine Rule Added Final

EP4426712A1 - Processable Compositions Patent

Favicon for changeflow.com EPO Patent Bulletin - Organic Chemistry (C07D)
Published
Detected
Email

Summary

The European Patent Office published patent application EP4426712A1 filed by Ripple Therapeutics Corporation on April 8, 2026. The patent covers processable compositions including steroidal compounds and heterocyclic derivatives with potential therapeutic applications spanning cardiovascular treatments, glaucoma, and ocular hypertension. The designated contracting states cover all major European Economic Area nations including Germany, France, the United Kingdom, Italy, Spain, and the Netherlands.

Published by EPO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The EPO published EP4426712A1, a patent application by Ripple Therapeutics Corporation for processable compositions and uses thereof. The patent covers heterocyclic compounds including C07D derivatives and steroidal compositions (C07J series) classified under multiple therapeutic categories including antihypertensives and ophthalmic treatments.

For pharmaceutical manufacturers and drug developers working in heterocyclic chemistry or steroidal compound derivatives, this patent grant establishes intellectual property protection across EPC contracting states. Companies pursuing generic or biosimilar development in these therapeutic areas should assess potential freedom-to-operate implications in the European market.

Archived snapshot

Apr 17, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← EPO Patent Bulletin

PROCESSABLE COMPOSITIONS AND USE FOR THE SAME

Publication EP4426712A1 Kind: A1 Apr 08, 2026

Applicants

Ripple Therapeutics Corporation

Inventors

PARRAG, Ian, Charles, STATHAM, Matthew, Alexander John, BATTISTON, Kyle, Giovanni, NAIMARK, Wendy, Alison, DAY, Jonathan, BALDWIN, Emily

IPC Classifications

C07J 41/00 20060101AFI20260302BHEP A61K 9/00 20060101ALI20260302BHEP A61K 47/54 20170101ALI20260302BHEP A61K 47/55 20170101ALI20260302BHEP A61P 9/12 20060101ALI20260302BHEP A61P 27/02 20060101ALI20260302BHEP A61P 27/10 20060101ALI20260302BHEP C07D 489/08 20060101ALI20260302BHEP C07J 5/00 20060101ALI20260302BHEP C07J 17/00 20060101ALI20260302BHEP C07J 31/00 20060101ALI20260302BHEP C07J 43/00 20060101ALI20260302BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Get daily alerts for EPO Patent Bulletin - Organic Chemistry (C07D)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from EPO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
EPO
Published
April 8th, 2026
Instrument
Rule
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
EP4426712A1

Who this affects

Applies to
Pharmaceutical companies Drug manufacturers Manufacturers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Patent publication IP protection
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Medical Devices

Get alerts for this source

We'll email you when EPO Patent Bulletin - Organic Chemistry (C07D) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!